Clinical Trial Update: Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 safety study evaluating the use of Elidel (pimecrolimus) 1% cream in Netherton Syndrome has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Netherton Syndrome

Drugs mentioned

• Elidel (pimecrolimus)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Netherton Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-12-12